Psychosocial Care for People with Diabetes. Deborah Young-Hyman
Читать онлайн книгу.
Child Health Care 38:91–106, 2009
Jeha GS, Karaviti LP, Anderson B, Smith EO, Donaldson S, McGirk T, Haymond MW: Continuous glucose monitoring and the reality of metabolic control in preschool children with type 1 diabetes. Diabetes Care 27:2881–2886, 2004
Jørgensen HV, Pedersen-Bjergaard U, Rasmussen AK, Borch-Johnsen K: The impact of severe hypoglycemia and impaired awareness of hypoglycemia on relatives of patients with type 1 diabetes. Diabetes Care 26:1106–1109, 2003
Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group, Tamborlane WV, Beck RW, Bode BW, Buckingham B, Chase HP, Clemons R, Fiallo-Scharer R, et al.: Continuous glucose monitoring and intensive treatment of type 1 diabetes. N Engl J Med 359:1464–1476, 2008
Katakura M, Naka M, Kondo T, Nishii N, Komatsu M, Sato Y, Yamauchi K, Hiramatsu K, Ikeda M, Aizawa T, Hashizume K: Prospective analysis of mortality, morbidity, and risk factors in elderly diabetic subjects: Nagano study. Diabetes Care 26:638–644, 2003
Kerr D, Macdonald IA, Heller SR, Tattersall RB: Alcohol causes hypoglycaemic unawareness in healthy volunteers and patients with type 1 (insulin-dependent) diabetes. Diabetologia 33:216–221, 1990
Kinsley BT, Weinger K, Bajaj M, Levy CJ, Simonson DC, Quigley M, Cox DJ, Jacobson AM: Blood glucose awareness training and epinephrine responses to hypoglycemia during intensive treatment in type 1 diabetes. Diabetes Care 22:1022–1028, 1999
Kordonouri O, Pankowska E, Rami B, Kapellen T, Coutant R, Hartmann R, Lange K, Knip M, Danne T: Sensor-augmented pump therapy from the diagnosis of childhood type 1 diabetes: results of the Paediatric Onset Study (ONSET) after 12 months of treatment. Diabetologia 53:2487–2495, 2010
Kubiak T, Hermanns N, Schreckling H-J, Kulzer B, Haak T: Evaluation of a self-management-based patient education program for the treatment and prevention of hypoglycemia-related problems in type 1 diabetes. Patient Educ Couns 60:228–234, 2006
Kubiak T, Hermanns N, Schreckling H-J, Kulzer B, Haak T: Assessment of hypoglycaemia awareness using continuous glucose monitoring. Diabet Med 21:487–490, 2004
Laiteerapong N, Karter AJ, Liu JY, Moffet HH, Sudore R, Schillinger D, John PM, Huang ES: Correlates of quality-of-life in older adults with diabetes: the Diabetes and Aging Study. Diabetes Care. doi: 10.2337/dc10-2424
Leese GP, Wang J, Broomhall J, Kelly P, Marsden A, Morrison W, Frier BM, Morris A: Frequency of severe hypoglycemia requiring emergency treatment in type 1 and type 2 diabetes: a population-based study of health service resource use. Diabetes Care 26:1176–1180, 2003
Leiter LA, Yale J-F, Chiasson J-L, Harris SB, Kleinstiver P, Sauriol L: Assessment of the impact of fear of hypoglycemic episodes on glycemic and hypoglycemic management. Can J Diabetes 29:186–192, 2005
Linkeschova R, Raoul M, Bott U, Berger M, Spraul M: Less severe hypoglycaemia, better metabolic control, and improved quality of life in type 1 diabetes mellitus with continuous subcutaneous insulin infusion (CSII) therapy: an observational study of 100 consecutive patients followed for a mean of 2 years. Diabet Med 19:746–751, 2002
Litton J, Rice A, Friedman N, Oden J, Lee MM, Freemark M: Insulin pump therapy in toddlers and preschool children with type 1 diabetes mellitus. J Pediatr 141:490–495, 2002
Lundkvist J, Berne C, Bolinder B, Jönsson L: The economic and quality of life impact of hypoglycemia. Eur J Health Econ 6:197–202, 2005
McCrimmon RJ, Frier BM: Hypoglycaemia, the most feared complication of insulin therapy. Diabetes Metab 20:503–512, 1994
Meloche RM: Transplantation for the treatment of type 1 diabetes. World J Gastroenterol 13:6347–6355, 2007
Mühlhauser I, Berger M: Diabetes education and insulin therapy: when will they ever learn? J Intern Med 233:321–326, 1993
Munshi MN, Segal AR, Suhl E, Staum E, Desrochers L, Sternthal A, Giusti J, McCarthy R, Lee Y, Bonsignore P, Weinger K: Frequent hypoglycemia among elderly patients with poor glycemic control. Arch Intern Med 171:362–364, 2011
Murata GH, Duckworth WC, Shah JH, Wendel CS, Mohler MJ, Hoffman RM: Hypoglycemia in stable, insulin-treated veterans with type 2 diabetes: a retrospective study of 1662 episodes. J Diabetes Complications 19:10–17, 2005
Murata GH, Hoffman RM, Shah JH, Wendel CS, Duckworth WC: A probabilistic model for predicting hypoglycemia in type 2 diabetes mellitus. Arch Intern Med 164:1445–1450, 2004
Myers VH, Boyer BA, Herbert JD, Barakat LP, Scheiner G: Fear of hypoglycemia and self-reported posttraumatic stress in adults with type I diabetes treated by intensive regimens. J Clin Psychol Med Settings 14:11–21, 2007
Nordfeldt S, Johansson C, Carlsson E, Hammersjo J-A: Persistent effects of a pedagogical device targeted at prevention of severe hypoglycaemia: a randomized, controlled study. Acta Paediatr 94:1395–1401, 2005a
Nordfeldt S, Ludvigsson J: Fear and other disturbances of severe hypoglycaemia in children and adolescents with type 1 diabetes mellitus. J Pediatr Endocrinol Metab 18:83–91, 2005b
Nordfeldt S, Johansson C, Carlsson E, Hammersjo J-A: Prevention of severe hypoglycaemia in type I diabetes: a randomised controlled population study. Arch Dis Child 88:240–245, 2003
Patton SR, Dolan LM, Henry R, Powers SW: Fear of hypoglycemia in parents of young children with type 1 diabetes mellitus. J Clin Psychol Med Settings 15:252–259, 2008
Perros P, Frier BM: The long-term sequelae of severe hypoglycemia on the brain in insulin-dependent diabetes mellitus. Horm Metab Res 29:197–202, 1997
Pettersson B, Rosenqvist U, Deleskog A, Journath G, Wändell P: Self-reported experience of hypoglycemia among adults with type 2 diabetes mellitus (Exhype). Diabetes Res Clin Pract 92:19–25, 2011
Plank J, Kohler G, Rakovac I, Semlitsch BM, Horvath K, Bock G, Kraly B, Pieber TR: Long-term evaluation of a structured outpatient education programme for intensified insulin therapy in patients with type 1 diabetes: a 12-year follow-up. Diabetologia 47:1370–1375, 2004
Rami B, Nachbaur E, Waldhoer T, Schober E: Continuous subcutaneous insulin infusion in toddlers. Eur J Pediatr 162:721–722, 2003
Ratner RE, Hirsch IB, Neifing JL, Garg SK, Mecca TE, Wilson C, on behalf of the U.S. Study Group of Insulin Glargine in Type 1 Diabetes: Less hypoglycemia with insulin glargine in intensive insulin therapy for type 1 diabetes. Diabetes Care 23:639–643, 2000
Reach G, Zerrouki A, Leclercq D, d’Ivernois J-F: Adjusting insulin doses: from knowledge to decision. Patient Educ Couns 56:98–103, 2005
Reviriego J, Gomis R, Marañés JP, Ricart W, Hudson P, Sacristán JA: Cost of severe hypoglycaemia in patients with type 1 diabetes in Spain and the cost-effectiveness of insulin lispro compared with regular human insulin in preventing severe hypoglycaemia. Int J Clin Pract 62:1026–1032, 2008
Rewers A, Chase HP, Mackenzie T, Walravens P, Roback M, Rewers M, Hamman RF, Klingensmith G: Predictors of acute complications in children with type 1 diabetes. JAMA 287:2511–2518, 2002
Richardson T, Weiss M, Thomas P, Kerr D: Day after the night before: influence of evening alcohol on risk of hypoglycemia in patients with type 1 diabetes. Diabetes Care 28:1801–1802, 2005
Rickels MR, Schutta MH, Mueller R, Kapoor S, Markmann JF, Naji A, Teff KL: Glycemic thresholds for activation of counterregulatory hormone and symptom responses in islet transplant recipients. J Clin Endocrinol Metab 92:873–879, 2007
Ritholz M: Is continuous glucose monitoring for everyone? Consideration of psychosocial factors. Diabetes Spectr 21:287–289, 2008
Rosenstock J, Dailey G, Massi-Benedetti M, Fritsche A, Lin Z, Salzman A: Reduced hypoglycemia risk with insulin glargine: a meta-analysis comparing insulin glargine with human NPH insulin in type 2 diabetes.